Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-04-038144
Filing Date
2004-12-02
Accepted
2004-12-02 13:05:09
Documents
2
Period of Report
2004-11-30

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 2952
2 EX-24 ex-24.htm EX-24 9206
  Complete submission text file 0001104659-04-038144.txt   14072
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Issuer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 15230 NW MITCHELL ST. PORTLAND OR 97227
Business Address 503-690-4485
Fox Bernard A (Reporting) CIK: 0001308867 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12493 | Film No.: 041179804